NewEdge Advisors’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-247
Closed -$4.49K 3986
2024
Q4
$4.49K Hold
247
﹤0.01% 3268
2024
Q3
$3.32K Hold
247
﹤0.01% 3282
2024
Q2
$3.42K Sell
247
-234
-49% -$3.7K ﹤0.01% 3201
2024
Q1
$9.01K Sell
481
-241
-33% -$4.82K ﹤0.01% 2929
2023
Q4
$16.3K Buy
+722
New +$15.7K ﹤0.01% 2652
2023
Q2
Sell
-101
Closed -$2.25K 3507
2023
Q1
$2.25K Sell
101
-4,955
-98% -$130K ﹤0.01% 3003
2022
Q4
$132K Buy
+5,056
New +$165K ﹤0.01% 1336

Other funds holding CCRN

NewEdge Advisors's CCRN Position: Q1 2025 in Review

NewEdge Advisors sold out of Cross Country Healthcare (CCRN) in Q1 2025, closing a stake of 247 shares — an estimated $4.49K sold.

NewEdge Advisors first reported a position in CCRN in Q4 2022 and held it in 7 quarters. The position peaked at $132K in Q4 2022. 161 funds tracked by Wall St. Rank hold CCRN as of Q1 2025.

  • NewEdge Advisors reported no remaining Cross Country Healthcare position as of Q1 2025 after selling out during the quarter.
  • NewEdge Advisors sold 247 Cross Country Healthcare shares in Q1 2025, an estimated $4.49K.
  • NewEdge Advisors first reported a position in Cross Country Healthcare in Q4 2022 and held it in 7 quarters.
  • NewEdge Advisors's Cross Country Healthcare position peaked at $132K in Q4 2022.
  • 161 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2025.

Based on NewEdge Advisors's 13F filing for Q1 2025, filed 15 May 2025.